Who owns Quoin Pharmaceuticals Ltd ADR?
- Ticker: QNRX
- CUSIP Number: 74907l409
Tip: Access positions for across all investors
Analyze quarterly positions in Quoin Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Quoin Pharmaceuticals stock
Who bought or sold Quoin Pharmaceuticals Ltd ADR this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ikarian Capital | 212k | $3.1M | 100% | Dec 2025 |
|
| Woodline Partners | 80k | $1.1M | 100% | Dec 2025 |
|
| Stonepine Capital Management | 78k | $1.1M | 100% | Dec 2025 |
|
| Standard Life Aberdeen | 75k | $1.1M | 100% | Dec 2025 |
|
| Millennium Management | 75k | $1.1M | 100% | Dec 2025 |
|
| SummitTX Capital | 65k | $935k | 100% | Dec 2025 |
|
| Boothbay Fund Management | 60k | $864k | 100% | Dec 2025 |
|
| ADAR1 Capital Management | 58k | $840k | 100% | Dec 2025 |
|
| AIGH Capital Management | 49k | $712k | 100% | Dec 2025 |
|
| Resolute Capital Asset Partners | 30k | $433k | 100% | Dec 2025 |
|
| Soleus Capital Management | 25k | $361k | 100% | Dec 2025 |
|
| Simplify Asset Management | 17k | $252k | 100% | Dec 2025 |
|
| Centiva Capital | 12k | $174k | 100% | Dec 2025 |
|
| GAMMA Investing | 1.7k | $11k | -17% | Mar 2026 |
|
| Rhumbline Advisers | 1.7k | $24k | 38% | Dec 2025 |
|
| SBI Securities | 247.00 | $3.6k | 12250% | Dec 2025 |
|
| UBS Group | 17.00 | $245.000600 | 1600% | Dec 2025 |
|